Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2023-08-17 00:00:00 ET · period of report 2023-08-16 · accession 0001048477-23-000039 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-17 | 2023-08-16 | BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Off | S - Sale | $90.00 | -5,000 | 60.8K | -8% | -$450.0K | |
| 2023-08-17 | 2023-04-28 | BMRN | Ajer Jeffrey Robert | EVP, Chief Commercial Off | A - Grant | $66.88 | +318 | 65.8K | +0.5% | +$21.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-16 | S | D | 5,000 | $90.00 | 60,804 | D | — | — | (F2) Trade made pursuant to a 10b5-1 plan executed on April 13, 2023. |
| 2 | Common | Common Stock | 2023-04-28 | A | A | 318 | $66.88 | 65,804 | D | — | — | (F1) Represents the shares acquired by the reporting person on April 28, 2023, pursuant to the issuer's Employee Stock Purchase Plan. |